bilaterals.org logo
bilaterals.org logo

Corporate interests

Behind every free trade and investment agreement lies a set of corporate interests. Just as they have greatly influenced the shape, scope and contents of World Trade Organization (WTO) agreements, so too are transnational corporations (TNCs), sectoral industry coalitions and lobby groups mobilizing around specific bilateral trade and investment negotiations, to push even further than they were able to get at the WTO.

“Bilateral and regional FTAs …are formalized manifestations of where our respective private sectors have taken us…it is really business and government moving in tandem,” explained Susan Schwab, former US Trade Representative in 2006.

TNCs, whether acting individually or as part of industry coalitions such as the US Council on International Business (USCIB), the Emergency Committee for International Trade, the Coalition of Service Industries (US), BusinessEurope, the European Services Forum (EU) or Nippon Keidanren (Japan), are organized, aggressive and influential in their demands for specific FTAs. The comprehensiveness of most free trade and investment agreements means that there are many cross-cutting issues as well as separate chapters and provisions in these agreements which serve to shape policy regimes in the interests of TNCs.

last update: May 2012
photo: Mehr Demokratie e.V.


Fair trade proving anything but in $6B market
Fair trade is increasingly becoming a marketing strategy where the farmers’ poverty is a necessary ingredient to make consumers feel good about themselves
Business leaders urge US, EU consider trade pact
The private sector Transatlantic Business Dialogue wants Obama and European Commission President Jose Manuel Barroso to agree when the two leaders meet on Monday to explore the idea of negotiating a "TransAtlantic Economic and Trade Pact."
Corporations occupy fair trade
Corporations move in to further occupy the fair trade network
Top U.S. companies urge new Internet trade rules
Google, Microsoft , Citigroup , IBM , GE and other top-tier American companies on Thursday urged the United States to fight for trade rules that protect the free flow of information over the Internet.
Kia closely watching free-trade debate
Kia spent $150,000 in the first quarter of this year to lobby members of the US House and Senate on matters that included the Korea-US free-trade agreement, according to federal lobbying records.
Alcohol lobbyists expose FTA pitfalls
Lobbyists for the alcohol industry are threatening to use New Zealand’s free trade agreements against government proposals to restrict products targetting young drinkers
Anti-free trade lobby is completely ignored by US Senators; Overseas producers and their interests control America’s economic policy
An aggressive lobbying and PR campaign aimed at defeating the proposed US free trade agreement with Korea, and costing hundreds of thousands of dollars, has amounted to nothing.
MAC applauds progress by Canadian government in the Americas
The Mining Association of Canada today offered congratulations to the federal government on the formal entry into force of the Canada-Colombia Free Trade Agreement effective August 15 2011.
Free trade deals: Lobbying fever foreshadows winners, losers
With so much attention being paid to the debt-ceiling hijinks, the major lobbying effort for the three trade bills — to ratify the US FTAs with Panama, Colombia and Korea — has been taking place almost entirely outside public view. But many of the biggest American companies have been engaged in a massive, months-long effort to get the bills passed.
SOCMA offers support for free trade pacts with South Korea, Panama, and Colombia
The Society of Chemical Manufacturers and Affiliates (SOCMA) issued its support this week of the passage of pending free-trade agreements (FTA) with South Korea, Panama and Colombia by two Congressional committees. SOCMA is the US-based trade association representing custom and batch manufacturers, including contract manufacturers of fine chemicals, pharmaceutical intermediates, and active pharmaceutical ingredients.